Free Trial

Apogee Therapeutics (APGE) News Today

Apogee Therapeutics logo
$34.92 -1.09 (-3.01%)
As of 11:18 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

APGE Latest News

Apogee Therapeutics Reports Positive Phase 2 Trial Results
Get Apogee Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for APGE and its competitors with MarketBeat's FREE daily newsletter.

APGE Media Mentions By Week

APGE Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

APGE
News Sentiment

1.19

0.39

Average
Medical
News Sentiment

APGE News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

APGE Articles
This Week

6

5

APGE Articles
Average Week

Get Apogee Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for APGE and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:APGE) was last updated on 8/8/2025 by MarketBeat.com Staff
From Our Partners